Table 3 Effects of CS EVO on plasmatic biomarkers in both healthy postmenopausal women and breast cancer patients
From: Nutrition, aging and cancer: lessons from dietary intervention studies
Variable | Baseline | After | p-valuea |
|---|---|---|---|
Cretininemia | 0.69 | 0.63 | <0.001 |
Uricemia | 4.23 | 4.43 | 0.002 |
Glycemia | 89.16 | 88.48 | 0.023 |
Glycated hemoglobin | 5.64 | 5.51 | <0.001 |
HDL cholesterol | 57.87 | 59.31 | 0.023 |
LDL cholesterol | 119.62 | 102.12 | 0.047 |
Testosterone | 0.39 | 0.36 | 0.033 |
Estradiol | 31.40 | 23.95 | 0.002 |